Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
10.75
+0.02 (0.19%)
At close: Sep 4, 2026, 4:00 PM EDT
10.86
+0.11 (1.02%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $940.6 million as of September 4, 2026. Its market cap has increased by 117.88% in one year.
Market Cap
940.60M
Enterprise Value
483.19M
1-Year Change
117.88%
Ranking
Category
Stock Price
$10.75
ChartMarket Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $940.60M, a decrease of -47.59%. That is a compound annual growth rate of -10.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 940.60M | -52.17% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 977.91M |
| SpyGlass Pharma | 967.98M |
| Adlai Nortye Group | 966.61M |
| Wave Life Sciences | 957.65M |
| Design Therapeutics | 947.49M |
| Ardelyx | 941.93M |
| Annexon | 923.25M |
| Rigel Pharmaceuticals | 909.15M |